×
About 17,465 results

ALLMedicine™ Allergic Rhinitis Center

Research & Reviews  4,463 results

Nasal irrigation with various solutions for adults with allergic rhinitis: A protocol f...
https://doi.org/10.1097/MD.0000000000031884
Medicine Widuri A, Rianto BUD et. al.

Dec 2nd, 2022 - Nasal douching or irrigation has been recommended for adjunctive therapy of sinonasal diseases including allergic rhinitis (AR) for many years. Previous study reported large-volume high-pressure device as an effective standard application, but the...

Trajectories of cough without a cold in early childhood and associations with atopic di...
https://doi.org/10.1111/cea.14257
Clinical and Experimental Allergy : Journal of the Britis... Divaret-Chauveau A, Mauny F et. al.

Dec 2nd, 2022 - Although children can frequently experience a cough that affects their quality of life, few epidemiological studies have explored cough without a cold during childhood. The objective of the study was to describe the latent class trajectories of co...

ASSOCIATION OF ADENOTONSILLECTOMY WITH WHEEZING EPISODES IN CHILDHOOD: A SECONDARY ANAL...
https://doi.org/10.1002/ppul.26252
Pediatric Pulmonology; Castro-Rodriguez JA, Biancardi F et. al.

Nov 30th, 2022 - Observational studies suggest that asthma/wheezing improve after adenotonsillectomy (AT). However, there is a paucity of RCT specifically studying the effects of AT in asthma/wheezing. Therefore, we conducted a post-hoc analysis of the Childhood A...

Monitoring of molecular profiling of allergen-antibody responses in HDM-immunotherapy p...
https://doi.org/10.1080/21645515.2022.2148815
Human Vaccines & Immunotherapeutics; Nittner-Marszalska M, Kopeć A et. al.

Nov 30th, 2022 - Among the potential hazards of HDM immunotherapy (AIT) with HDM allergenic extracts is the possible initiation of de novosensitizations caused by a lack of complementarity between a given HDM vaccine's content and a patient's molecular sensitizati...

Management of Anaphylaxis During Peanut Oral Immunotherapy.
https://doi.org/10.1007/s11882-022-01054-x
Current Allergy and Asthma Reports; Szafron V, Anagnostou A

Nov 30th, 2022 - Peanut oral immunotherapy (POIT) has emerged as an active management option for peanut allergy, with an FDA-approved product now available for therapy. Allergic reactions, including anaphylaxis, can occur during therapy and their management is key...

see more →

Guidelines  9 results

Screening for Lung Cancer
https://www.aafp.org/afp/2021/0700/p79.html
American Family Physician; Tracer H, Pierre J.

Jul 7th, 2021 - S.J., a 68-year-old Black man, comes to your office to establish care after recently moving to the area. S.J. has a history of allergic rhinitis, osteoarthritis, and gastroesophageal reflux disease. Additionally, he has a 39-pack-year history of s...

European Position Paper on Rhinosinusitis and Nasal Polyps 2020.
https://doi.org/10.4193/Rhin20.600
Rhinology Fokkens WJ, Lund VJ et. al.

Feb 23rd, 2020 - The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012. The core objective of the EPOS2020 guideline is to provide revised, up-to-date and cle...

Clinical practice guidelines for the management of olfactory dysfunction - Secondary pu...
https://doi.org/10.1016/j.anl.2019.04.002
Auris, Nasus, Larynx; Miwa T, Ikeda K et. al.

May 12th, 2019 - To provide an evidence-based recommendation for the management of olfactory dysfunction in accordance with the consensus reached by the Subcommittee of the Japanese Clinical Practice Guideline for olfactory dysfunction in the Japanese Rhinologic S...

Pharmacologic Treatment of Seasonal Allergic Rhinitis: Synopsis of Guidance From the 20...
https://doi.org/10.7326/M17-2203
Annals of Internal Medicine; Wallace DV, Dykewicz MS et. al.

Nov 29th, 2017 - The Joint Task Force on Practice Parameters, which comprises representatives of the American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI), formed a workgroup to review evidenc...

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision.
https://doi.org/10.1016/j.jaci.2017.03.050
The Journal of Allergy and Clinical Immunology; Brożek JL, Bousquet J et. al.

Jun 13th, 2017 - Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of life and school and work performance and is a frequent reason for office visits in general practice. Medical costs are large, but avoidable costs associated with lo...

see more →

Drugs  1,226 results see all →

Clinicaltrials.gov  835 results

Natural History of Severe Allergic Inflammation and Reactions
https://clinicaltrials.gov/ct2/show/NCT01164241

Oct 13th, 2022 - Allergic inflammation is central to the pathogenesis of allergic diseases, including atopic dermatitis, asthma, allergic rhinitis, and food allergy. These disorders are common, affecting up to 50 million Americans, and their pathophysiology remain...

Oral Findings in Pediatric Patients With Allergic Rhinitis and/or Asthma
https://clinicaltrials.gov/ct2/show/NCT05576142

Oct 12th, 2022 - The aim of the study was to evaluate if there were differences in oral findings between patients diagnosed with allergic rhinitis and/or asthma and a control group of health people. At the oral evaluation, the following indexes were calculated: PS...

Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR
https://clinicaltrials.gov/ct2/show/NCT05570383

Oct 6th, 2022 - Allergic rhinitis (AR) has become a major chronic respiratory inflammatory disease and is considered to be one of the global refractory diseases. and it has become an important global health problem. The treatment of AR mainly includes environment...

Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis
https://clinicaltrials.gov/ct2/show/NCT05098522

Oct 6th, 2022 - The purpose of this allergen challenge study is to assess the efficacy of IRL201104 compared with placebo in adult participants with seasonal allergic rhinitis.

Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen
https://clinicaltrials.gov/ct2/show/NCT05540717

Sep 29th, 2022 - Multi-centre, randomised, parallel group, double-blind, placebo-controlled clinical trial to confirm the efficacy and safety of the optimal effective dose of PQ Grass (27600 SU). Randomized study subjects, in a randomisation ratio of 1:1, will rec...

see more →

News  422 results

Rhinitis Patients Report Symptomatic Medication Use in Mobile App
https://www.medscape.com/viewarticle/984571

Nov 23rd, 2022 - Patients with rhinitis treat their condition as symptoms arise, rather than by guidelines on how to keep their disease under control, suggests a longitudinal study that confirms cross-sectional analyses. Investigators captured data from patients i...

Add Tezepelumab to SCIT to Improve Cat Allergy Symptoms?
https://www.medscape.com/viewarticle/984335

Nov 18th, 2022 - The asthma medication tezepelumab, added to subcutaneous immunotherapy treatment (SCIT), may provide better, longer-lasting symptom relief than allergy shots alone for patients with allergic rhinitis caused by cat allergens, according to results o...

Adherence to Subcutaneous Allergen Immunotherapy Is Suboptimal
https://www.medscape.com/viewarticle/983629

Nov 7th, 2022 - A recent systematic review of real-world data that was published in the International Forum of Allergy and Rhinology shows that persistence and adherence to subcutaneous allergen immunotherapy is suboptimal, suggesting that many patients with alle...

How Long Will Allergy Patients Take Sublingual Immunotherapy?
https://www.medscape.com/viewarticle/983234

Oct 28th, 2022 - How long patients with allergic rhinitis adhere to sublingual immunotherapy (SLIT) appears to vary, but further, more rigorous research is needed, results of a systematic literature review suggest. Dr Scott P. Commins "This systematic review found...

Evidence Mounting That Full-Body Emollients Don't Prevent Eczema in At-Risk Babies
https://www.medscape.com/viewarticle/982685

Oct 19th, 2022 - MONTREAL — Daily use of full-body emollients from birth to age 1 year in infants at high risk for developing atopic dermatitis (AD) was not more effective at preventing the condition than standard skin-care advice alone, according to 5-year result...

see more →

Patient Education  31 results see all →